Anticoagulants Flashcards
what are the 4 phases of hemostasis
- vascular spasm
- platelet plug formation (primary hemostasis)
- blood coagulation (2ndary hemostasis)
- dissolution of fibrin clot (tertiary hemostasis)
what is Virchow’s triad and what is its importance
endothelial injury, abnormal flow of blood, and hypercoagulability
they predispose one to formation of a thrombus
classes of drugs that are used to reduce clotting
- platelet aggregation inhibitors
- anticoagulants
- thrombolytics
classes of drugs that are used to treat bleeding
- plasminogen activation inhibitors
- protamine sulfate
- vitamin K
- plasma fractions
platelet aggregation inhibitor are useful in the prevention and treatment of
cardiovascular diseases
maintenance of vascular grafts and arterial patency
adjuncts in treatment of MI
what are the platelet aggregation inhibitors
GAAP
- GP IIb/IIIa inhibitors: abciximab, eptifibatide, tirofiban
- Aspirin
- ADP receptor inhibitors: Clopidogrel, ticlopidine
- Phosphodiesterase inhibitor: Cilostazol, Dipyridamole
mechanism of aspirin
it inhibits thromboxane synthesis by irreversible acetylation of enzyme COX hence it is a COX inhibitor
why is aspirin better than other NSAIDs
it can acetylate COX and is irreversible hence its action lasts longer than the reversible action of other NSAIDs
what is aspirin used for
- prophylactic tx of transient cerebral ischemia
- reduce incident of recurrent MI
- reduce mortality in post MI patient
name the ADP receptor blockers and their mechanism
clopidogrel and ticlopidine
inhibit P2Y12 irreversibly (ADP receptor on platelet surface) –> reduced platelet aggregation
adverse effects of ADP receptor blockers (name the drugs again)
clopidogrel and ticlopidine
thrombocytopenia pupura
but ticlopidine can cause neutropenia
how is clopidogrel activated and what are conditions that can cause it not to be activated
- it is a prodrug that is activated by CYP2C19
- if someone is a poor metabolizer of CYP2C19 or takes omeprazole (CYP2C19 inhibitor), then they would have less of the active metabolite in their plasma
uses of clopidogrel and ticlopidine (more clopidogrel though)
reduce the rate of stroke, MI, death in pts with recent MI or stroke, established peripheral artery disease, or acute coronary syndrome
mechanism of dipyridamole
inhibits phosphodiesterase and/or blocks adenosine uptake –> increase in cAMP –> activates adenylyl cyclase –> coronary vasodilation
uses of dipyridamole
- little to no benefit if taken alone
- with warfarin it prevents post op thromboembolic complication of cardiac valve replacement
- with aspirin it’s a prophylaxis for cerebrovascular disease